Saturday, May 12, 2007

Acorda Therapeutics CEO receives $1.41M in compensation
Business in the Burbs - White Plains,NY,USA
The company is seeking to develop Fampridine-SR, a drug that could help multiple sclerosis patients walk. This entry was posted by Allan Drury on Wednesday, ...
See all stories on this topic

0 Comments:

Post a Comment

<< Home